D.W. Miles

Activity of type IV collagenases in benign and malignant breast disease

B Davies, D.W. Miles, LC Happerfield et al. · British Journal of Cancer · 1993 · 333 citations · Full text

Breast Oncology, Mammary Gland, Pathology +7

Enhancing the Effect of THERATOPE STn-KLH Cancer Vaccine in Patients with Metastatic Breast Cancer by Pretreatment with Low-Dose Intravenous Cyclophosphamide

Grant D. MacLean, D.W. Miles, R.D. Rubens et al. · Journal of Immunotherapy · 1996 · 157 citations

Biomarker results from the AVADO phase 3 trial of first-line bevacizumab plus docetaxel for HER2-negative metastatic breast cancer

D.W. Miles, Sanne Lysbet de Haas, Luc Dirix et al. · British Journal of Cancer · 2013 · 154 citations · Full text

A randomised phase II study of sialyl-Tn and DETOX-B adjuvant with or without cyclophosphamide pretreatment for the active specific immunotherapy of breast cancer

D.W. Miles, KE Towlson, Rosalind Graham et al. · British Journal of Cancer · 1996 · 104 citations · Full text

Cyclophosphamide Pretreatment, Breast Oncology, Oncology +9

LBA15 Primary results from IMpassion131, a double-blind placebo-controlled randomised phase III trial of first-line paclitaxel (PAC) ± atezolizumab (atezo) for unresectable locally advanced/metastatic triple-negative breast cancer (mTNBC)

D.W. Miles, Joseph Gligorov, Fabrice André et al. · Annals of Oncology · 2020 · 97 citations

Breast Oncology, Oncology, Lba15 Primary Results +8